2008, Número 1
<< Anterior Siguiente >>
Rev Med UV 2008; 8 (1)
El papel inmunorregulador del factor de crecimiento transformante beta (TGF-¦Â) en las infecciones parasitarias
L¨®pez MA , Ramos LA
Idioma: Español
Referencias bibliográficas: 32
Paginas: 38-44
Archivo PDF: 656.73 Kb.
RESUMEN
Los miembros de la superfamilia del factor de crecimiento transformante-beta (TGF-¦Â) son factores de crecimiento que son secretados y poseen varias funciones importantes en laproliferaci¨®n, diferenciaci¨®n y adhesi¨®n celular. La familia del TGF-¦Â est¨¢ dividida en tres grupos principales: los TGF-¦Âs, las activinas y las prote¨ªnas morfogen¨¦ticas del hueso (BMP¡¯s). Enlos mam¨ªferos existen tres isoformas de TGF-¦Â, los TGF-¦Â 1, 2 y 3. La isoforma TGF-¦Â se encuentra de forma predominante en la mayor¨ªa de los tejidos, y es producida por varios tipos celulares del linaje de los leucocitos, en donde se incluyen linfocitos, macr¨®fagos, c¨¦lulas dendr¨ªticas y plaquetas, y su expresi¨®n act¨²a tanto en una forma aut¨®crina como paracrina para controlar los procesos mencionados anteriormente. Sin embargo, actualmente la activaci¨®n del TGF-¦Â latente (inactivo); en consecuencia, unaproducci¨®n elevada de esta citosina ha sido ligada a defectos inmunes asociados con enfermedades y des¨®rdenes autoinmunes, susceptibilidad a infecciones oportunistas y a complicaciones fibr¨®ticas asociadas a condiciones inflamatorias cr¨®nicas. En este trabajo, el objetivo fue el de realizar una revisi¨®n de las propiedades inmunorregulatorias del TGF-¦Â en el contexto de las infecciones parasitarias.
REFERENCIAS (EN ESTE ARTÍCULO)
Wahl SM. Transforming growth factor-β: The good, the bad and the ugly. J. Exp. Med., 1994; 180: 1587-1590.
Stavnezer J. Regulation of antibody production and class switching by TGF-β1. J. Immnunol., 1995; 156: 1647-1651.
Omer FM, Kurtzhals JAL., and Riley EM. (2000) Maintaining the immunological balance in parasitic infections: A role for TGF-β? Parasitol. Today, 2000; 16: 18-23.
Yu Q, Stamenkovic I. Cell surface-localized matrizmetalloprotease-9 proteolytically activates TGF-β and promotes tumor invasion and angiogenesis. Genes Dev 2000; 14:163-76.
Wrana JL. y cols. Mechanism of activation of the TGF-β receptor. Nature, 1994; 370: 341-347.
Abbas AK, Lichtman AH. Pober JS. In Martin J. Wonsiewicz WB. Editors. Cellular and Molecular Immunology. (Martin J. y Wonsiewicz, W. B. eds), Saunders Co. Philadelphia, USA. 1996
Mosmann TR. Coffman RL. Th1 and Th2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol., 1989; 7:145-173.
Groux, H. et al. A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature, 1997; 389: 737-742.
Letterio JJ.Roberts AB. Regulation of immune responses by TGF-beta. Annu. Rev. Immunol., 1998;16: 137-161.
Cools N. Ponsaerts P. Van TendelooVFI. Berneman ZN. Regulatory T cells and human disease. Clin Dev Immunol 2007; 2007:89195
Pereira ME. A developmentally regulated neuraminidase activity Trypanosoma cruzi. Science, 1983; 219: 1444-1446.
Waghabi MC. Keramidas M. Feige JJ. Araujo- Jorge TC. Bailly S. Activation of transforming growth factor beta by Trypanosoma cruzi. Cell Microbiol 2005;7:511-7
Templeton TJ. Kaslow DC. Cloning and crossspecies comparison of the thrombospondin-related anonymous protein (TRAP) gene from Plasmodium knowlesi, Plasmodium vivax and Plasmodium gallinaceum. Mol. Biochem. Parasitol., 1997; 84: 13-24.
Omer FMM.de Souza JB. Corran PH. Sultan AA. Riley EM. Activation of transforming growth factor beta by malaria parasite-derived metalloproteinases and thrombospondin-like molecule. J Exp Med 2003; 198:1817-27.
Fitzpatrick DR.Bielefeldt-Ohmann H. Transforming growth factor β in infectious disease: always there for the host and the pathogen. Trends Microbiol., 1999; 7: 232-236.
Wassner SC de Souza JB Frere C. Candal FJ. Juthan-Vagua II. Grau GE. TGF-beta 1 released from activated parasites can induce TNF-stimulated human brain endothelium apoptosis: a new mechanism for microvascular lesion during cerebral malaria. J Immunol 2006; 15: 1180-4.
Nagineri CN. Detrick B. Hooks JJ. Transforming growth factor-b expression in human retinal pigment epithelial cells is enhanced by Toxoplasma gondii: a possible role in the immunopathogenesis of retinochoroiditis. Clin Exp Immunol 2002; 128: 372-78.
López-Monteon A. et al. Modulated TGF-beta response in the hamster model in response to immunization with the recombinant L1b protein from Entamoeba histolytica. Arch. Med. Res, 2000; 31: S81-S83.
Melby PC. Tryon VV. Chandrasekar B. Freeman GL. Cloning of syrian hamster (Mesocricetus auratus) cytokine cDNAs and analysis of cytokine mRNA expression in experimental visceral leishmaniasis. Infect. Immun. 1998; 66: 2135- 2142.
Wilson ME. et al. The importance of TGF-b in murine visceral leishmaniasis. J. Immunol., 1998; 161: 6148-6155.
Caldas A. Favali C. Aquino D. Vinhas V. Weyenbergh J. et al. Balance of IL-10 and interferon- γ plasma levels in human visceral leishmaniasis: Implications in the pathogenesis. BMC Infect Dis 2005; 5.113.
Imai S. Fujita K. Molecules of parasites as immunomodulatory drugs. Curr Top Med Chem 2004; 4: 539-52.
Ribeiro de Jesus A. Magalhaes A. Gonzalez Miranda D. Gonzalez Miranda R. Araújo MI. Almeida de Jesús A. et al. Association of type 2 cytokines with hepatic fibrosis in human Schistosoma mansoi infection. Infect Immune 2004; 72: 339-97.
Alvess Oliveira LF. Moreno EC. Gazzinelli G.Martins-Filho OA. Silveira AMS. Gazzinelli A. et al. Cytokine production associated with periportal fibrosis during chronic Schistosomiasis mansoni in humans. Infect Immun 2006; 74: 1251-21.
Waghabi MC. Keramidas M. Calvet CM. Meuser M. Soeiro MNC. Mendonca-Lima L. et al. SB-431542 a transforming growth factor β inhibitor impairs Tripanosoma cruzi infection in cardiomyocites and parasites cycle completion. Antimicrob Agents Chemother 2007; 51: 2905-10.
Kariminia A. Bourreau E. Pascalis H. Couppié P. Saint-Marie D. Tacchini-Cothier F. et al. Transforming growth factor β1 production byCD4+ CD25+ regulatoru T cells in peripheral blood mononuclear cells from healthy subjects stimulated with Leishmania guyanensis. Infect Immun 2005; 73: 5908-14.
Li C. Sanni LA. Omer F. Riley E. Langhome J. Pathology of Plasmodium chabaudi chabaudi infection and mortality in interleukin 10-deficient mice are ameliorated by anti-tumor necrosis factor α and exacerbated by anti-trasnforming growth factor β antibodies. Infect Immun 2003; 71: 4850-56,
Omer FM. Riley EM. Transforming growth factos β production is inversely correlated with severity of murine malaria infection. J EXP Med 1998; 188: 39-48.
Tsunawak S. Sporn M. Ding A.Nathan C. Deactivation of macrophages by transforming growth factor-beta. Nature, 1988; 334: 260-262.
Omer FM de Souza JB. Riley EM. Differential induction of TGFβ regulates proinflammatory cytokine production and determines the outcome of letal and non letal Plasmodium yoelii infections. J Immunol 2003; 171:5430-36.
Walther M. Tongren JE. Andrews L. Korbel D. King E. Fletcher H. et al. Upregulation of TGFβ, FOXP3 and CD4+ CD25+ T cells correlates with more rapid parasite growth in human malaria infection. Immunity 2005; 23: 287-96.
Brunet L. R.. et al. Cytokine interaction and immune responses during Schistosoma mansoni infection. Parasitol. Today, 1998;14: 422-427.